These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7891289)

  • 1. Approaches to analysis of aggregates and demonstrating mass balance in pharmaceutical protein (basic fibroblast growth factor) formulations.
    Shahrokh Z; Stratton PR; Eberlein GA; Wang YJ
    J Pharm Sci; 1994 Dec; 83(12):1645-50. PubMed ID: 7891289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic methods for quantitative analysis of native, denatured, and aggregated basic fibroblast growth factor in solution formulations.
    Sluzky V; Shahrokh Z; Stratton P; Eberlein G; Wang YJ
    Pharm Res; 1994 Apr; 11(4):485-90. PubMed ID: 8058602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the conformation of protein (bFGF) precipitates by fluorescence spectroscopy.
    Shahrokh Z; Eberlein G; Wang YJ
    J Pharm Biomed Anal; 1994 Aug; 12(8):1035-41. PubMed ID: 7819377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant.
    Hutcheon CJ; Becker JO; Russell BA; Bariola PA; Peterson GJ; Stroop SD
    Vaccine; 2006 Nov; 24(49-50):7214-25. PubMed ID: 16860908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute on-line molecular mass analysis of basic fibroblast growth factor and its multimers by reversed-phase liquid chromatography with multi-angle laser light scattering detection.
    Astafieva IV; Eberlein GA; Wang YJ
    J Chromatogr A; 1996 Aug; 740(2):215-29. PubMed ID: 8765649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of various excipients on the unfolding of basic fibroblast growth factor.
    Shah D; Johnston TP; Heitz S; Mitra AK
    PDA J Pharm Sci Technol; 1998; 52(5):209-14. PubMed ID: 9846068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation.
    Kiese S; Pappenberger A; Friess W; Mahler HC
    J Pharm Sci; 2010 Feb; 99(2):632-44. PubMed ID: 19548315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size exclusion HPLC method for the determination of acidic fibroblast growth factor in viscous formulations.
    Bruner MW; Goldstein J; Middaugh CR; Brooks MA; Volkin DB
    J Pharm Biomed Anal; 1997 Aug; 15(12):1929-35. PubMed ID: 9278899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and simple methods for quantitative analysis of some antidepressant in pharmaceutical formulations by using first derivative spectrophotometry and HPLC.
    Erk N
    Farmaco; 2003 Dec; 58(12):1209-16. PubMed ID: 14630230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone.
    Charman SA; Mason KL; Charman WN
    Pharm Res; 1993 Jul; 10(7):954-62. PubMed ID: 8378257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous-bed chromatography for the analysis and purification of recombinant human basic fibroblast growth factor.
    Garke G; Radtschenko I; Anspach FB
    J Chromatogr A; 1999 Oct; 857(1-2):137-44. PubMed ID: 10536832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous detection and analysis of protein aggregation and protein unfolding by size exclusion chromatography with post column addition of the fluorescent dye BisANS.
    Printz M; Friess W
    J Pharm Sci; 2012 Feb; 101(2):826-37. PubMed ID: 22095720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
    Wu Z; Razzak M; Tucker IG; Medlicott NJ
    J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stoichiometry of heparin binding to basic fibroblast growth factor.
    Arakawa T; Wen J; Philo JS
    Arch Biochem Biophys; 1994 Jan; 308(1):267-73. PubMed ID: 8311463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some Lessons Learned From a Comparison Between Sedimentation Velocity Analytical Ultracentrifugation and Size Exclusion Chromatography to Characterize and Quantify Protein Aggregates.
    Gandhi AV; Pothecary MR; Bain DL; Carpenter JF
    J Pharm Sci; 2017 Aug; 106(8):2178-2186. PubMed ID: 28479353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis.
    Shimoyama Y; Gotoh M; Ino Y; Sakamoto M; Kato K; Hirohashi S
    Jpn J Cancer Res; 1991 Nov; 82(11):1263-70. PubMed ID: 1721615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity.
    Gabrielson JP; Brader ML; Pekar AH; Mathis KB; Winter G; Carpenter JF; Randolph TW
    J Pharm Sci; 2007 Feb; 96(2):268-79. PubMed ID: 17080424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of oxybutynin immediate-release and controlled-release formulations.
    Varma MV; Kaushal AM; Garg S
    J Pharm Biomed Anal; 2004 Nov; 36(3):669-74. PubMed ID: 15522548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.